Vol 10 Issue 2

CELL AND GENE THERAPY INSIGHTS

March 2024 Issue

Vol 10 Issue 2

Download PDF

Featuring

Issue Spotlight: Non-clinical/translational tools & technologies
Scalability 2024
Other articles
Webinars

SPOTLIGHT

Non-clinical/translational tools & technologies
Shon Green
Guest Editor:
Shon Green, Director, Clinical Translation at Adicet Bio

Foreword

The March 2024 issue of Cell & Gene Therapy Insights

The March 2024 issue of Cell & Gene Therapy Insights

Shon Green
2 April
Read

Expert Insight

Preclinical trends in developing genetically altered cell therapies

Preclinical trends in developing genetically altered cell therapies

Mary Ellen Cosenza
25 March
Read

Interview

The preclinical journey: transitioning a novel cell therapy into early phase clinical trials

The preclinical journey: transitioning a novel cell therapy into early phase clinical trials

Silvio Manfredo-Vieira
6 March
Read
Evolution in the landscape of non-clinical safety testing for advanced therapies

Evolution in the landscape of non-clinical safety testing for advanced therapies

Michaela Sharpe
19 January
Read

Viewpoint

Regulatory and scientific considerations for building translational cell and gene therapy packages

Regulatory and scientific considerations for building translational cell and gene therapy packages

Shannon Dahl
23 February
Read

Vectors FOCUS

Scalability 2024

Interview

Advancing AAV production scalability: enhancing purity, productivity, and yield

Advancing AAV production scalability: enhancing purity, productivity, and yield

Ashish Saksule
19 March
Read

FastFacts

Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Johanna Viiliäinen
19 March
Read

Innovator Insight

Advancing gene therapy development with a multi-serotype AAV affinity resin

Advancing gene therapy development with a multi-serotype AAV affinity resin

Nicolas Laroudie, Quentin Bazot
4 April
Read

Journal articles

Interview

Quantitative viral vector characterization: prioritizing genome vector integrity

Quantitative viral vector characterization: prioritizing genome vector integrity

David Dobnik
21 February
Read
Gene therapy is having a monumental year: how can the industry keep up with supply?

Gene therapy is having a monumental year: how can the industry keep up with supply?

Suman Subramanian
4 April
Read

FastFacts

Dissolvable microcarriers: a modular, high-yield solution for seed train through production

Dissolvable microcarriers: a modular, high-yield solution for seed train through production

Tom Bongiorno
14 March
Read

Webinar Digest

What goes into developing an in-house method for quantitation of residual host cell DNA?

What goes into developing an in-house method for quantitation of residual host cell DNA?

Ilaria Scarfone
12 March
Read

Poster

5 best practices for lentiviral purification and downstream processing success

5 best practices for lentiviral purification and downstream processing success

4 April
Read
5 dos and don'ts for regulatory compliance in AAV manufacturing

5 dos and don'ts for regulatory compliance in AAV manufacturing

4 April
Read

Webinars